Nakornthon Hospital Public Company Limited

As of June 30, 2026, Nakornthon Hospital Public Company Limited NVDR carries a market capitalization of 2.04B, placing it among publicly traded companies globally. Its enterprise value stands at 2.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nakornthon Hospital Public Company Limited NVDR's next confirmed earnings release is scheduled for December 17, 2026.

As of June 30, 2026, Nakornthon Hospital Public Company Limited NVDR has 535.00M shares outstanding.

As of June 30, 2026, Nakornthon Hospital Public Company Limited NVDR trades at a trailing price-to-earnings ratio of 17.79. The price-to-sales ratio is 1.04, and the price-to-book ratio stands at 1.05.

As of June 30, 2026, Nakornthon Hospital Public Company Limited NVDR trades at an EV/EBITDA multiple of 6.49 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.11 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 12.40 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.20B versus a market cap of 2.04B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Nakornthon Hospital Public Company Limited NVDR maintains a current ratio of 1.46, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 22.59, indicating elevated leverage, while an interest coverage ratio of 59.74 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Nakornthon Hospital Public Company Limited NVDR posted a return on equity (ROE) of 6.01, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 5.46 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.44, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.47, useful for judging operating efficiency across full business cycles. Inventory turnover of 42.07 indicates how many times Nakornthon Hospital Public Company Limited NVDR sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Nakornthon Hospital Public Company Limited NVDR recorded 55.67M in income tax expense. That works out to an effective tax rate of 32.37, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 171.99M, leaving 116.32M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Nakornthon Hospital Public Company Limited NVDR's stock has declined approximately 7.96% over the past 52 weeks. The 50-day moving average sits at 3.70, while the 200-day moving average is 3.90.

Over the twelve months ended June 30, 2026, Nakornthon Hospital Public Company Limited NVDR generated 1.99B in revenue and converted that into 116.32M in net income, yielding earnings per share of 0.21. EBITDA reached 339.60M, while operating income came in at 177.68M.

As of June 30, 2026, Nakornthon Hospital Public Company Limited NVDR holds 278.45M in cash and equivalents against 438.64M in total debt, resulting in a net debt position of 71.55M. Total book value stands at 1.94B, with working capital of 137.15M providing operational flexibility.

Nakornthon Hospital Public Company Limited NVDR produced 362.05M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -929.37M in capital expenditures, free cash flow totaled -567.33M - equivalent to -1.05 per share.

Over the twelve months ended June 30, 2026, Nakornthon Hospital Public Company Limited NVDR posted a gross margin of 25.65, reflecting its pricing power and cost economics. The operating margin of 8.92 and net profit margin of 5.84 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Nakornthon Hospital Public Company Limited NVDR paid dividends of 0.18 per share. The dividend payout ratio of 81.63 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -27.42: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -12.48, meaning Nakornthon Hospital Public Company Limited NVDR raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Nakornthon Hospital Public Company Limited NVDR has an Altman Z-Score of 2.69, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.